The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation.

[1]  B. Fauser,et al.  Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. , 2017, Fertility and sterility.

[2]  A. Więcek,et al.  Serum Anti-Müllerian Hormone Concentration in Young Women with Chronic Kidney Disease on Hemodialysis, and After Successful Kidney Transplantation , 2016, Kidney and Blood Pressure Research.

[3]  P. Mark,et al.  Obstetric and long‐term kidney outcomes in renal transplant recipients: a 40‐yr single‐center study , 2016, Clinical transplantation.

[4]  D. Barad,et al.  What affects functional ovarian reserve, thyroid function or thyroid autoimmunity? , 2016, Reproductive Biology and Endocrinology.

[5]  E. Anckaert,et al.  Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination. , 2016, Clinical biochemistry.

[6]  S. Iliodromiti,et al.  Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. , 2015, Human reproduction update.

[7]  H. Tournaye,et al.  Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values. , 2015, Human Reproduction.

[8]  L. Nardo,et al.  Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool. , 2015, Fertility and sterility.

[9]  D. Gassner,et al.  First fully automated immunoassay for anti-Müllerian hormone , 2014, Clinical chemistry and laboratory medicine.

[10]  R. Fanchin,et al.  The physiology and clinical utility of anti-Mullerian hormone in women. , 2014, Human reproduction update.

[11]  A. Franx,et al.  Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian aging. , 2014, The Journal of clinical endocrinology and metabolism.

[12]  J. Piette,et al.  Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  S. Iliodromiti,et al.  Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. , 2013, The Journal of clinical endocrinology and metabolism.

[14]  W. Wallace,et al.  Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. , 2013, Fertility and sterility.

[15]  S. Nelson.  Biomarkers of ovarian response: current and future applications. , 2013, Fertility and sterility.

[16]  M. Solaymani-Dodaran,et al.  Modeling age at menopause using serum concentration of anti-mullerian hormone. , 2013, The Journal of clinical endocrinology and metabolism.

[17]  R. Rey,et al.  Male hypogonadism: an extended classification based on a developmental, endocrine physiology‐based approach , 2013, Andrology.

[18]  J. Forman,et al.  Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. , 2012, Reproductive biomedicine online.

[19]  T. K. Jensen,et al.  Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study. , 2012, Fertility and sterility.

[20]  V S Kalaiselvi,et al.  The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cycles. , 2012, Journal of clinical and diagnostic research : JCDR.

[21]  R. Rey,et al.  Testicular Anti-Müllerian Hormone: Clinical Applications in DSD , 2012, Seminars in Reproductive Medicine.

[22]  Raymond Vanholder,et al.  Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.

[23]  N. Raine-Fenning,et al.  Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti‐Müllerian hormone and small antral follicle count using three‐dimensional ultrasound , 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[24]  You Js.  Ovarian aging and implications for fertility female health. , 2012 .

[25]  S. Chow,et al.  Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's) , 2011, Arthritis care & research.

[26]  S. McDonald,et al.  Pregnancy and maternal outcomes among kidney transplant recipients. , 2009, Journal of the American Society of Nephrology : JASN.

[27]  M. Tonelli,et al.  The Pregnancy Rate and Live Birth Rate in Kidney Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[29]  P. Neven,et al.  The Role of Inhibins B and Antimüllerian Hormone for Diagnosis and Follow-up of Granulosa Cell Tumors , 2009, International Journal of Gynecologic Cancer.

[30]  S. Nakajima,et al.  Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. , 2008, Fertility and sterility.

[31]  S. Constantinescu,et al.  Pregnancy after kidney transplantation. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[32]  J. Davison,et al.  Chronic kidney disease in pregnancy , 2008, BMJ : British Medical Journal.

[33]  A. Volpe,et al.  The Anti-Mullerian hormone and ovarian cancer. , 2007, Human reproduction update.

[34]  J. Stark,et al.  Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. , 2005, The Journal of clinical endocrinology and metabolism.

[35]  J. Weisinger,et al.  Outcomes associated with hypogonadism in women with chronic kidney disease. , 2004, Advances in chronic kidney disease.

[36]  L. Rienzi,et al.  Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. , 2002, Human reproduction.

[37]  D. Seifer,et al.  Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. , 2002, Fertility and sterility.

[38]  F. Dumler,et al.  Gynecologic and reproductive issues in women on dialysis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  S. Agarwal,et al.  A mechanism for the suppression of estrogen production in polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[40]  S. Sunkara,et al.  Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. , 2014, Human reproduction update.

[41]  P. Jungers,et al.  Pituitary and ovarian dysfunctions in women on haemodialysis. , 1982, Nephron.